DOSSIER · 13F Holders · Q2 2026
FDMT
4D MOLECULAR THERAPEUTICS IN
157 institutions still hold 4D MOLECULAR THERAPEUTICS IN as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 35104E100·157 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
157 institutions reported FDMT in Q2 2026. Jupiter Topco LLC leads at 12.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 8
137 more holders available. Log in →